Patents Assigned to Xencor, Inc.
  • Proteins with insulin-like activity useful in the treatment of diabetes
    Patent number: 6746853
    Abstract: The invention relates to novel insulin activity (IA) proteins and nucleic acids. The Invention further relates to the use of the IA proteins in the treatment of insulin related disorders such as type 1 diabetes and type 2 diabetes.
    Type: Grant
    Filed: May 19, 2000
    Date of Patent: June 8, 2004
    Assignee: Xencor, Inc.
    Inventors: Bassil I. Dahiyat, Andrew G. Morton
  • Recombinant interferon-beta muteins
    Patent number: 6514729
    Abstract: The invention relates to novel interferon-beta activity (IbA) proteins and nucleic acids. The invention further relates to the use of the IbA proteins in the treatment of IFN-&bgr; related disorders.
    Type: Grant
    Filed: May 11, 2000
    Date of Patent: February 4, 2003
    Assignee: Xencor, Inc.
    Inventor: Jörg Bentzien